Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dasatinib With Ifosfamide, Carboplatin, Etoposide: A Pediatric Phase I/II Trial

NCT00788125 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00788125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00788125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dasatinib With Ifosfamide, Carboplatin, Etoposide: A Pediatric Phase I/II Trial
Lead sponsor
City of Hope Medical Center
Phase
Phase 1/2
Overall status
Terminated
Start date
September 3, 2008
Completion date
July 30, 2022
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, childhood germ cell tumor, extragonadal germ cell tumor, kidney cancer, liver cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, testicular germ cell tumor, unspecified childhood solid tumor, protocol specific